Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$19.72 - $28.68 $1.24 Million - $1.8 Million
-62,815 Reduced 35.74%
112,934 $3.11 Million
Q3 2023

Nov 09, 2023

SELL
$22.33 - $29.92 $271,711 - $364,066
-12,168 Reduced 6.48%
175,749 $3.92 Million
Q2 2023

Aug 14, 2023

BUY
$20.96 - $26.99 $297,632 - $383,258
14,200 Added 8.17%
187,917 $4.79 Million
Q1 2023

May 04, 2023

BUY
$20.58 - $27.89 $702,909 - $952,582
34,155 Added 24.47%
173,717 $3.87 Million
Q4 2022

Feb 02, 2023

SELL
$15.31 - $29.94 $65,771 - $128,622
-4,296 Reduced 2.99%
139,562 $3.31 Million
Q3 2022

Nov 14, 2022

BUY
$16.58 - $27.9 $31,734 - $53,400
1,914 Added 1.35%
143,858 $2.39 Million
Q2 2022

Aug 12, 2022

SELL
$15.45 - $29.52 $1.23 Million - $2.35 Million
-79,717 Reduced 35.96%
141,944 $2.83 Million
Q1 2022

May 09, 2022

BUY
$21.94 - $42.51 $1.36 Million - $2.63 Million
61,872 Added 38.72%
221,661 $6.11 Million
Q4 2021

Feb 10, 2022

BUY
$36.09 - $53.79 $1.23 Million - $1.83 Million
34,023 Added 27.05%
159,789 $6.58 Million
Q3 2021

Nov 09, 2021

SELL
$35.62 - $52.97 $44,346 - $65,947
-1,245 Reduced 0.98%
125,766 $5.84 Million
Q2 2021

Aug 12, 2021

BUY
$32.94 - $56.62 $327,687 - $563,255
9,948 Added 8.5%
127,011 $5.08 Million
Q1 2021

May 12, 2021

BUY
$44.47 - $81.38 $282,517 - $517,007
6,353 Added 5.74%
117,063 $6.29 Million
Q4 2020

Feb 12, 2021

BUY
$32.49 - $61.88 $946,368 - $1.8 Million
29,128 Added 35.7%
110,710 $5.42 Million
Q3 2020

Nov 12, 2020

BUY
$26.73 - $35.67 $72,865 - $97,236
2,726 Added 3.46%
81,582 $2.65 Million
Q2 2020

Aug 04, 2020

SELL
$19.49 - $28.11 $706,298 - $1.02 Million
-36,239 Reduced 31.49%
78,856 $2.04 Million
Q1 2020

May 04, 2020

SELL
$16.13 - $30.17 $279,597 - $522,966
-17,334 Reduced 13.09%
115,095 $2.8 Million
Q4 2019

Feb 10, 2020

SELL
$20.78 - $29.99 $1.7 Million - $2.45 Million
-81,623 Reduced 38.13%
132,429 $3.7 Million
Q3 2019

Oct 22, 2019

SELL
$23.87 - $30.93 $581,783 - $753,856
-24,373 Reduced 10.22%
214,052 $5.14 Million
Q2 2019

Aug 15, 2019

SELL
$22.1 - $28.56 $1.62 Million - $2.1 Million
-73,389 Reduced 23.54%
238,425 $6.8 Million
Q1 2019

May 15, 2019

SELL
$12.0 - $25.76 $95,064 - $204,070
-7,922 Reduced 2.48%
311,814 $7.8 Million
Q4 2018

Feb 06, 2019

BUY
$9.15 - $14.85 $40,717 - $66,082
4,450 Added 1.41%
319,736 $4.02 Million
Q3 2018

Oct 16, 2018

BUY
$9.55 - $12.64 $100,571 - $133,111
10,531 Added 3.46%
315,286 $3.01 Million
Q2 2018

Jul 17, 2018

BUY
$5.39 - $9.66 $353,201 - $633,010
65,529 Added 27.39%
304,755 $2.85 Million
Q1 2018

Apr 26, 2018

SELL
$5.44 - $6.97 $72,041 - $92,303
-13,243 Reduced 5.25%
239,226 $1.33 Million
Q4 2017

Feb 05, 2018

BUY
$6.05 - $9.37 $413,003 - $639,643
68,265 Added 37.06%
252,469 $1.65 Million
Q3 2017

Oct 30, 2017

BUY
$7.81 - $8.77 $1.44 Million - $1.62 Million
184,204
184,204 $1.62 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.97B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.